Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: Ten-year results from the IBSEN study

Journal of Crohn's and Colitis

Volumn 6, Issue 4, 2012, Pages 441-453

  Høivik, Marte Lie ^a   Bernklev, Tomm ^c   Solberg, Inger Camilla ^a   Cvancarova, Milada ^a   Lygren, Idar ^a   Jahnsen, Jørgen ^a   Moum, Bjørn ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c TELEMARK HOSPITAL   (Norway)

Author keywords

Crohn's disease (CD); Epidemiology; Health related quality of life (HRQoL); Minimal clinically important difference (MCID); Population based; Quality of life (QoL)

Indexed keywords

ADULT; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DISEASE DURATION; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SHORT FORM 36; STRUCTURED INTERVIEW; STUDENT T TEST;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHRONIC DISEASE; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84860153131     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.10.001     Document Type: Article

References (51)

1. Freeman H.J. Long-term natural history of Crohn's disease. World J Gastroenterol 2009, 15:1315-1318.
2. Travis S.P., Stange E.F., Lemann M., Oresland T., Chowers Y., Forbes A., et al. European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006, 55(Suppl. 35). [221 refs].
3. Wolters F.L., Russel M.G., Stockbrugger R.W. Systematic review: has disease outcome in Crohn's disease changed during the last four decades?. Aliment Pharmacol Ther 2004, 20:483-496. [Review, 200 refs].
4. Nordin K., Pahlman L., Larsson K., Sundberg-Hjelm M., Loof L. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol 2002, 37:450-457.
5. Bernklev T., Jahnsen J., Lygren I., Henriksen M., Vatn M., Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005, 11:909-918.
6. Bernklev T., Jahnsen J., Aadland E., Sauar J., Schulz T., Lygren I., et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004, 39:365-373.
7. Rubin G.P., Hungin A.P., Chinn D.J., Dwarakanath D. Quality of life in patients with established inflammatory bowel disease: a UK general practice survey. Aliment Pharmacol Ther 2004, 19:529-535.
8. Casellas F., Vivancos J.L., Sampedro M., Malagelada J.R. Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life. Am J Gastroenterol 2005, 100:2737-2742.
9. Graff L.A., Walker J.R., Lix L., Clara I., Rawsthorne P., Rogala L., et al. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol 2006, 4:1491-1501.
10. Canavan C., Abrams K.R., Hawthorne B., Drossman D., Mayberry J.F. Long-term prognosis in Crohn's disease: factors that affect quality of life. Aliment Pharmacol Ther 2006, 23:377-385.
11. Casellas F., Lopez-Vivancos J., Badia X., Vilaseca J., Malagelada J.R. Impact of surgery for Crohn's disease on health-related quality of life. Am J Gastroenterol 2000, 95:177-182.
12. Bernklev T., Jahnsen J., Henriksen M., Lygren I., Aadland E., Sauar J., et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:402-412.
13. Solberg I.C., Vatn M.H., Hoie O., Stray N., Sauar J., Jahnsen J., et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007, 5:1430-1438.
14. Hoivik M.L., Bernklev T., Moum B. Need for standardization in population-based quality of life studies: a review of the current literature. Inflamm Bowel Dis 2010, 16:525-536. [Review, 52 refs].
15. Moum B., Ekbom A., Vatn M.H., Aadland E., Sauar J., Lygren I., et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997, 32:1005-1012.
16. Henriksen M., Jahnsen J., Lygren I., Aadland E., Schulz T., Vatn M.H., et al. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol 2007, 42:602-610.
17. Guyatt G., Mitchell A., Irvine E.J., Singer J., Williams N., Goodacre R., et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989, 96:804-810.
18. Bernklev T., Moum B., Moum T., Inflammatory Bowel South-Eastern Norway (IBSEN) Group of Gastroenterologists Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scand J Gastroenterol 2002, 37:1164-1174.
19. Ware J.E., Snow K., Kosinski M., Gandek B. SF-36 health survey manual and interpretation guide 1993, The Health Institute, New England Medical Center.
20. Ware J.E., Gandek B. Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol 1998, 51:903-912.
21. Ware J.E., Kosinski M., Keller S. SF-36 physical and mental health summary scales: a user's manual 1994, The Health Institute, New England Medical Center.
22. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
23. Loge J.H., Kaasa S. Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 1998, 26:250-258.
24. Loge J.H., Abrahamsen A.F., Ekeberg O., Kaasa S. Reduced health-related quality of life among Hodgkin's disease survivors: a comparative study with general population norms. Ann Oncol 1999, 10:71-77.
25. World Health Organization. Iron Deficiency Anemia Assessment, Prevention and Control A guide for programme managers. Report. 2011WHO/NHP/01.3.
26. Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000, 6:8-15.
27. Guyatt G., Schunemann H. How can quality of life researchers make their work more useful to health workers and their patients?. Qual Life Res 2007, 16:1097-1105. [Review, 48 refs].
28. Turner D., Schunemann H.J., Griffith L.E., Beaton D.E., Griffiths A.M., Critch J.N., et al. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol 2010, 63:28-36.
29. Coteur G., Feagan B., Keininger D.L., Kosinski M. Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease. Aliment Pharmacol Ther 2009, 29:1032-1041.
30. Hlavaty T., Persoons P., Vermeire S., Ferrante M., Pierik M., Van A.G., et al. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm Bowel Dis 2006, 12:199-204.
31. Higgins P.D., Schwartz M., Mapili J., Krokos I., Leung J., Zimmermann E.M. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut 2005, 54:782-788.
32. Cohen J. Statistical power analysis for the behavioural sciences 1988, Lawrence Erlbaum Associates. 2nd ed.
33. Iglesias M., Vazquez I., Barreiro-de A.M., Figueiras A., Nieto L., Pineiro M., et al. Health related quality of life in patients with Crohn's disease in remission. Rev Esp Enferm Dig 2010, 102:624-630.
34. Pihl-Lesnovska K., Hjortswang H., Ek A.C., Frisman G.H. Patients' perspective of factors influencing quality of life while living with Crohn disease. Gastroenterol Nurs 1945, 33:37-44.
35. Stjernman H., Tysk C., Almer S., Strom M., Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scand J Gastroenterol 2010, 45:696-706.
36. Banovic I., Gilibert D., Cosnes J. Crohn's disease and fatigue: constancy and co-variations of activity of the disease, depression, anxiety and subjective quality of life. Psychol Health Med 2010, 15:394-405.
37. Guthrie E., Jackson J., Shaffer J., Thompson D., Tomenson B., Creed F. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol 2002, 97:1994-1999.
38. Jelsness-Jorgensen L.P., Bernklev T., Henriksen M., Torp R., Moum BrA Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm Bowel Dis 2011, 17:1564-1572.
39. Romberg-Camps M.J.L., Bol Y., Dagnelie P.C., Hesselink-van de Kruijs M.A.M., Kester A.D.M., Engels L.G.J.B., et al. Fatigue and health-related quality of life in inflammatory bowel disease: Results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010, 16:2137-2147.
40. Lix L.M., Graff L.A., Walker J.R., Clara I., Rawsthorne P., Rogala L., et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:1575-1584.
41. Blondel-Kucharski F., Chircop C., Marquis P., Cortot A., Baron F., Gendre J.P., et al. Groupe d'Etudes Therapeutique des Affections Inflammatoires Digestives (GETAID). Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 2001, 96:2915-2920.
42. Yazdanpanah Y., Klein O., Gambiez L., Baron P., Desreumaux P., Marquis P., et al. Impact of surgery on quality of life in Crohn's disease. Am J Gastroenterol 1997, 92:1897-1900.
43. Casellas F., Arenas J.I., Baudet J.S., Fabregas S., Garcia N., Gelabert J., et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005, 11:488-496.
44. Gibson P.R., Weston A.R., Shann A., Florin T.H., Lawrance I.C., Macrae F.A., et al. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol 2007, 22:1306-1312.
45. Freeman H.J. Use of the Crohn's disease activity index in clinical trials of biological agents. World J Gastroenterol 2008, 14:4127-4130.
46. Maunder R.G., Greenberg G.R. Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis. Inflamm Bowel Dis 2004, 10:632-636.
47. Solem C.A., Loftus E.V., Tremaine W.J., Harmsen W.S., Zinsmeister A.R., Sandborn W.J. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:707-712.
48. Pizzi L.T., Weston C.M., Goldfarb N.I., Moretti D., Cobb N., Howell J.B., et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:47-52.
49. Wells C.W., Lewis S., Barton J.R., Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006, 12:123-130.
50. Goodnough L.T., Nissenson A.R. Anemia and its clinical consequences in patients with chronic diseases. Am J Med 2004, 116(Suppl. 2S).
51. Farrokhyar F., Marshall J.K., Easterbrook B., Irvine E.J. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis 2006, 12:38-46.